Targeting Pim kinases for cancer treatment: opportunities and challenges
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Pim kinases for cancer treatment: opportunities and challenges
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 7, Issue 1, Pages 35-53
Publisher
Future Science, LTD
Online
2015-01-13
DOI
10.4155/fmc.14.145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers
- (2014) P. D. Garcia et al. CLINICAL CANCER RESEARCH
- PIM Kinases Are Essential for Chronic Lymphocytic Leukemia Cell Survival (PIM2/3) and CXCR4-Mediated Microenvironmental Interactions (PIM1)
- (2014) S. Decker et al. MOLECULAR CANCER THERAPEUTICS
- A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas
- (2014) Jason M. Foulks et al. NEOPLASIA
- Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design
- (2013) Xiaojing Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
- (2013) E. K. Keeton et al. BLOOD
- Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update
- (2013) Gubbi M Arunesh et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice
- (2013) Ningfei An et al. Journal of Hematology & Oncology
- The PIM Family of Serine/Threonine Kinases in Cancer
- (2013) Maja Narlik-Grassow et al. MEDICINAL RESEARCH REVIEWS
- Activities at the Universal Protein Resource (UniProt)
- (2013) NUCLEIC ACIDS RESEARCH
- Pim-1 Kinase Phosphorylates and Stabilizes 130 kDa FLT3 and Promotes Aberrant STAT5 Signaling in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication
- (2013) Karthika Natarajan et al. PLoS One
- Crystal Structure of Pim1 Kinase in Complex with a Pyrido[4,3-D]Pyrimidine Derivative Suggests a Unique Binding Mode
- (2013) Sang Jae Lee et al. PLoS One
- The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B
- (2013) Ke Ren et al. PROSTATE
- Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors
- (2013) Matthew T. Burger et al. ACS Medicinal Chemistry Letters
- Role of PRAS40 in Akt and mTOR signaling in health and disease
- (2012) Claudia Wiza et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities
- (2012) Carmen Blanco-Aparicio et al. BIOCHEMICAL PHARMACOLOGY
- Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors
- (2012) Joaquín Pastor et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases
- (2012) Les A. Dakin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Abstract 3762: Second generation PIM inhibitors exhibit improved activity in solid tumor models
- (2012) Jason M. Foulks et al. CANCER RESEARCH
- Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition
- (2012) Sebastian Blanck et al. DALTON TRANSACTIONS
- PIM1 kinase as a target for cancer therapy
- (2012) Anna Lena Merkel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy
- (2012) Denis Drygin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors
- (2012) Marjo Malinen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Abstract C200: Second-generation PIM inhibitors exhibit improved activity in solid tumor models in vitro.
- (2012) J. M. Foulks et al. MOLECULAR CANCER THERAPEUTICS
- The PIM kinases in hematological cancers
- (2012) Yesid Alvarado et al. Expert Review of Hematology
- A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors
- (2011) Michèle N. Schulz et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity
- (2011) Fabrice Pierre et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
- (2011) L. S. Chen et al. BLOOD
- Targeting PIM kinase activity significantly augments the efficacy of cytarabine
- (2011) Kevin R. Kelly et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pim Kinase Inhibitors Sensitize Prostate Cancer Cells to Apoptosis Triggered by Bcl-2 Family Inhibitor ABT-737
- (2011) J. H. Song et al. CANCER RESEARCH
- Roles of Pim-3, a novel survival kinase, in tumorigenesis
- (2011) Naofumi Mukaida et al. CANCER SCIENCE
- The Pim Kinases: New Targets for Drug Development
- (2011) Ronan Swords et al. CURRENT DRUG TARGETS
- The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms
- (2011) Methvin Isaac et al. DRUG RESISTANCE UPDATES
- Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking
- (2011) Ji-Xia Ren et al. Journal of Chemical Information and Modeling
- Overexpression of Pim-1 in bladder cancer
- (2011) Shengjie Guo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pim family of protein kinases: Structure, functions, and roles in hematopoietic malignancies
- (2011) Yu. N. Zhukova et al. MOLECULAR BIOLOGY
- Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
- (2011) J Wang et al. ONCOGENE
- PIM1 Protein Kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells
- (2010) Fengxue Zhang et al. CANCER BIOLOGY & THERAPY
- CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
- (2010) A. Siddiqui-Jain et al. CANCER RESEARCH
- Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors
- (2010) F. Anizon et al. CURRENT MEDICINAL CHEMISTRY
- 123 Anti-tumor activity of CXR1002, a novel anti-cancer clinical phase compound that induces ER stress and inhibits PIM kinases: Human tumor xenograft efficacy and in vitro mode of action
- (2010) A. Barnett et al. EJC SUPPLEMENTS
- Pim kinase inhibitors: a survey of the patent literature
- (2010) Tina Morwick EXPERT OPINION ON THERAPEUTIC PATENTS
- New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights
- (2010) Miriam López-Ramos et al. FASEB JOURNAL
- Why target PIM1 for cancer diagnosis and treatment?
- (2010) Nancy S Magnuson et al. Future Oncology
- PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
- (2010) L. Brault et al. HAEMATOLOGICA
- Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma
- (2010) Hong-Tao Liu et al. JOURNAL OF SURGICAL ONCOLOGY
- p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase
- (2010) M. Zemskova et al. MOLECULAR CANCER RESEARCH
- The Pim protein kinases regulate energy metabolism and cell growth
- (2010) Z. Beharry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase
- (2009) Ron Grey et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
- (2009) L. S. Chen et al. BLOOD
- Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines
- (2009) Jie Li et al. EXPERIMENTAL HEMATOLOGY
- 14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2 - Potential interplay with the PKB/Akt pathway and p14ARF
- (2009) Nicola T. Wood et al. FEBS LETTERS
- PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications
- (2009) Min En Nga et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration
- (2009) Rebekka Grundler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hit to Lead Account of the Discovery of a New Class of Inhibitors of Pim Kinases and Crystallographic Studies Revealing an Unusual Kinase Binding Mode†
- (2009) Kevin Qian et al. JOURNAL OF MEDICINAL CHEMISTRY
- PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis
- (2009) J J Gu et al. ONCOGENE
- The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
- (2008) G. Wernig et al. BLOOD
- Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
- (2008) D. Morishita et al. CANCER RESEARCH
- 332 POSTER In vivo activity of SGI-1776, an orally active Pim kinase inhibitor
- (2008) D. Bearss et al. EJC SUPPLEMENTS
- Potential roles for the PIM1 kinase in human cancer – A molecular and therapeutic appraisal
- (2008) Nilesh Shah et al. EUROPEAN JOURNAL OF CANCER
- Elevated Levels of Oncogenic Protein Kinase Pim-1 Induce the p53 Pathway in Cultured Cells and Correlate with Increased Mdm2 in Mantle Cell Lymphoma
- (2008) Carol Hogan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Serine/Threonine Kinase Pim-2 Promotes Liver Tumorigenesis Induction Through Mediating Survival and Preventing Apoptosis of Liver Cell
- (2008) Jianping Gong et al. JOURNAL OF SURGICAL RESEARCH
- Pim kinase-dependent inhibition of c-Myc degradation
- (2008) Y Zhang et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now